In addition, miR-362 and miR-20a have been reported to activate the NF-κB signaling pathway and upregulate the expression of NF-κB-regulated genes by targeting CYLD, leading to the enhancement of the CDDP resistance of GC cells (131, 132). This evidence concerns the gene NFKB1 and gastric cancer.